C-erb B2 oncoprotein expression: Correlation with the Ki-67 labeling index and AgNOR counts in breast carcinoma on fine needle aspiration cytology

Acta Cytologica

Volumn 40, Issue 6, 1996, Pages 1217-1220

  Sinha, Sanjay K ^a   Singh, Usha R ^a   Bhatia, Arati ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Aspiration biopsy; Breast neoplasms; Carcinoma; Ki 67; Nucleolus organizer regions; Oncoproteins

Indexed keywords

KI 67 ANTIGEN; ONCOPROTEIN;

ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0030479426     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333983     Document Type: Article

References (23)

1. Bargmann CI, Hung MC, Weinberg RA: The Neu-oncogene encodes an epidermal growth factor related protein. Nature 1986;319:226-230
2. Barnard NJ, Hall PA, Lemoine NR, Kadar N: Proliferative index in breast carcinoma, determined in situ by Ki-67 im-munostaining and its relation to clinical and pathological variables. J Pathol 1987;152:287-295
3. Charpin C, Andrai L, Vacheret H, Habib MC, Devictor B, Lavaut MN, Toga M: Multiparametric evaluation of growth fraction (Monoclonal Ki-67) in breast cancer tissue section. Cancer Res 1988;48:4368-4374
4. Crocker J, Boldy D, Egan J: How should we count AgNORs?: Proposals for a standardized approach. J Pathol 1989;158: 185-188
5. Derenzini M, Pession A, Farabegoli F, Badiali M, Dehaw P: Relationship between interphasic nucleolar organizer and growth rate in two neuroblastoma cell lines. Am J Pathol 1989;134:925-932
6. Gerdes J, Schwab UJ, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31:13-20
7. Guillaud P, du Mandir S, Seigneurin D: Quantification and topographical description of Ki-67 antibody labeling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumor cell lines (MCF-7). Anal Cell Pathol 1989;1:25-39
8. Hall PA, Crocker J, Watts A, Stansfield AG: A comparison of nucleolar organizer region staining and Ki-67 immunostain-ing in non-Hodgkin's lymphoma. Histopathology 1988;12: 373-381
9. Jan Mohamed RM, Armstrong SJ, Crocker J, Leyland MJ, Hulten MA: The relationship between the number of interphase NOR's and NOR bearing chromosomes in non-Hodgkin's lymphoma. J Pathol 1989;188:3-7
10. Lemoine NR, Staddon S, Dickson C, Barnes DM, Gullick WJ: Absence of activating transmembrane mutation in the C-erb B2 proto-oncogene in human breast cancer. Oncogene 1990;5:237-239
11. Mouriquand J, Gozlan-Fior M, Villeman D, Bouchet Y, Sage YC, Mermet MA, Boll M: Value of cytoprognostication in breast carcinoma. J Clin Pathol 1986;39:489-496
12. Nicholson RI, McClelland RA, Finlay P, Eaton CL, Gullick WJ, Dixon AR, Robertson JFR, Ellis IO, Blamey RW: Relationship between EGFR, C-erb B2 protein expression and Ki-67 immunostaining in breast cancer. Eur J Cancer 1993;29: 1018-1023
13. Parkin DM, Stjernsward J, Muir CS: Estimates of the frequency of twelve major cancers. Bull WHO 1984;62:163-182
14. Ploton D, Menager M, Geannesson P, Humber G, Pigeon F, Adnett JJ: Improvement in the staining and in the visualization of the argyrophilic proteins of nucleolar organizer regions at the optical level. Histochem J 1986;18:5-14
15. Quirke P, Pickles A, Tuzi NL, Mohamadee O, Gullick WJ: Pattern of expression of C-erb B2 oncoprotein in human fetuses. Br J Cancer 1989;60:64-69
16. Ramchandra S, Machin L, Monaghan P, Gusterson BA: Im-munohistochemical distribution of C-erb B2 in in-situ breast carcinoma: A detailed morphological analysis. J Pathol 1990; 161:7-14
17. Rishi M, Schwarting R, Kovatich AJ, Ehya H: Detection of growth fraction in tumor by Ki-67 monoclonal antibody in cytologic smears: A prospective study of 40 cases. Diagn Cy-topathol 1993;9:52-56
18. Slamon DJ, Clare GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of HER-2/neu oncogene. Science 1987;235:177-182
19. Tandon AK, Clark GM, Chamnes GL, Ullrich A, McGuire WL: HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 1989;7:1120-1128
20. Trere D, Farabegoli F, Cancellier A, Cecalrelli C, Eusebi V, Derenzini M: AgNOR area in interphase nuclei of human tumours correlates with proliferative activity evaluated by Bromodeoxyuridine labelling and Ki-67 immunostaining. J Pathol 1991;168:53-59
21. Van De Vijuer MJ, Petrse JL, Mooi WJ, Wisnan P, Lonians J, Dalesio O, Nusse R: Neu-protein over expression in breast cancer: Association of comedo type ductal carcinoma in situ and limited prognostic value in stage III breast cancer. N Engl J Med 1988;319:1239-1245
22. Veronese SM, Gambacarta M, Gattardi O, Scanzi F, Ferrani M, Lampentico P: Proliferative index as a prognostic marker in breast cancer. Cancer 1993;71:3926-301
23. World Health Organization: Histological Typing of Breast Tumors. Second edition. Geneva, WHO, 1981, p 19